Clinical Trial

SUNOSI® (Solriamfetol) Pregnancy Registry

Recruiting
View on ClinicalTrials.gov →
Summary
The SUNOSI (solriamfetol) Pregnancy Registry is a prospective, multi-country, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).
Trial Details
NCT Number NCT06413420
Lead Sponsor Axsome Therapeutics, Inc.
Conditions Narcolepsy, Obstructive Sleep Apnea, Pregnant Women and Their Offspring
Enrollment 1,731 participants
Start Date 2019-07-31
Primary Completion 2029-09 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2024-05-14